None listed
Conditions
Interventions
None listed
Sponsors
Seoul National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Pediatric patients <18 years old who received the off-labeled medication since 2005
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2.Vital sign - inotropics/vasopressor ;3.Neurophysiologic monitoring - EEG, BIS;4. Biochemical variable- ? Immunoglobulin, cytokine, B-type natriuretic peptide;1. Efficacy variable 1)Sedatives: sedatino scale 2)Analgesics and local anesthetics: FLACC scale,? Oucher scale, Visual analogue scale 3)Antibiotics: fever. lab finding, radiologic finding, clinical findings 4)Anticancer drug: change in size of cancer and staging, radiologic finding, clinical manifestation, mortality, 5)Antiepileptic drug: relief of symptom, EEG finding | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse effect | — |
Countries
Korea, Republic of
Contacts
Public ContactHee-Soo Kim
Seoul National University Hospital
Outcome results
None listed